Cherian S.,Potdar V.,Jadhav S.,Yadav P.,Gupta N.,M. Das P.,Rakshit S.,Singh P.,Abraham S.,Panda S. .2021 ."Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-. Apr, : .
Volz E.,Mishra S.,Chand M.,Barrett J. C.,Johnson R.,Hinsley W. R.,Laydon D. J.,Á. O'Toole D. J. . .. "Assessing transmissibility of SARSCoV-2 lineage B.1.1.7 in England," Nature, 593 : .
.2021 .. , : 269.
Russell D. C.,Tully A. D.,Washburne A. D. .2021 ."Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England,". Science, 372(6538) : .
Kim Y. J.,Jang U. S.,Soh S. M.,Lee J. Y.,Lee H. R. .2021 ."The Impact on infectivity and neutralization efficiency of SARS-CoV-. lineage B.1.351 pseudovirus," Viruses, 13(633) : .
Robillard J.,Puech J. .2021 ."Reduced sensitivity of SARSCoV-2 variant delta to antibody neutralization,". Nature, 596 : 276-280.
Wang P.,Casner R. G.,Nair M. S.,Wang M.,Yu J.,Cerutti G.,Kwong P. D.,Huang Y.,Shapiro L. .2021 ."Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization," bioRxiv, Mar. , : .
. .National Institutes of Health, "COVID-19 Treatment Guidelines-Therapeutic Management of Nonhospitalized Adults With COVID-19.". , : .
.2021 .. Accessed: Jul. 28, : .
. .European Centre for Disease Prevention and Control, "Risk of SARS-CoV-2 Transmission from Newly-Infected Individuals with Documented Previous Infection or. , : .
Hou Y. J.,Okuda K.,Edwards C. E.,Martinez D. R.,Asakura T.,Dinnon K. H.,Kato T.,Lee R. E.,Yount B. L.,Mascenik T. M. .2020 ."SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract,". Cell, 05 : 429-446.
M. Meselson ,Med N. Engl. J. .2020 ."Droplets and aerosols in the transmission of SARS-CoV-2,". , 382 : .
Little P.,Read R. C.,Amlôt R.,Chadborn T.,Rice C.,Bostock J.,Yardley L. .2020 ."Reducing risks from coronavirus transmission in the home-the role of viral load,". BMJ, 369 : m1728.
Collier D. A.,A. De Marco I.,Ferreira B.,Meng R. P.,Datir A. C.,Walls S. A.,Kemp J.,Bassi D.,Pinto C.,Silacci-Fregni C. .2021 ."Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies,". Nature, 593 : 136-141.
C. K. Wibmer F.,Ayres T.,Hermanus M.,Madzivhandila P.,Kgagudi B. E.,Lambson M.,Vermeulen K. van der,Berg K. van der .2021 ."SARSCoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma,". Nat. Med, 27 : 622-625.
Korber B.,Fischer W. M.,Gnanakaran S.,Yoon H.,Theiler J.,Abfalterer W.,Hengartner N.,Giorgi E. E. . .. , : .
Bhattacharya B.,Foley B. . ."Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus,". Cell, 182 : .
.2020 .. , 06 : 827.
Galloway S. E.,Paul P.,MacCannell D. R.,Johansson M. A.,Brooks J. T.,Slayton A. MacNeil,Tong S.,Silk B. J.,Armstrong G. L.,Lineage-United States .2021 .". Mortal. Wkly. Rep, 70 : 95-99.
Meng B.,Kemp S. A.,Datir R.,Marelli S.,Harvey W. T.,Lytras S.,Mohamed A.,Gallo G. .2021 ."Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7,". Cell Rep, 109292 : 109292.
Tegally M.,Giovanetti A.,Iranzadeh V.,Fonseca J.,Giandhari D.,Doolabh S.,Pillay E. J.,San N.,Msomi N. .2021 ."Detection of a SARS-CoV-2 variant of concern in South Africa,". Nature, 592 : 438-443.
.2022 .of-novel-sars-cov-2-variant-variant-of-concern20201201. Accessed: Apr. 13, : .